• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6 1.52% $3.90

CLARITY PHARMACEUTICALS LTD

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
CU6
CU6 - Media and Industry News
2
09/05/24 110 38K
09/05/24 Last post  ma420 Comments Created with Sketch.  110  Views Created with Sketch.  38K 
CU6
Clarity Pharma has been featured in the latest Thematic Insights Report - Download now!
09/05/24 10 2.7K
09/05/24 Last post  Hingdog Comments Created with Sketch.  10  Views Created with Sketch.  2.7K 
CU6
CU6 - ASX Charts
5 6 7
09/05/24 398 115K
Metals & Mining SECTOR NEWS

Alara Resources is driving Oman into a renewable renaissance with accelerating copper production

AUQ
10 May 2024
ALARA RESOURCES LIMITED
09/05/24 Last post  ttppxx Comments Created with Sketch.  398  Views Created with Sketch.  115K 
CU6 06/05/24 90 34K
06/05/24 Last post  24TIGES Comments Created with Sketch.  90  Views Created with Sketch.  34K 
CU6
Research/Valuation
5 6 7
05/05/24 375 113K
05/05/24 Last post  Tapples Comments Created with Sketch.  375  Views Created with Sketch.  113K 
CU6 04/05/24 71 20K
04/05/24 Last post  Taurean7 Comments Created with Sketch.  71  Views Created with Sketch.  20K 
CU6 03/05/24 4 1.4K
03/05/24 Last post  Coit Comments Created with Sketch.  4  Views Created with Sketch.  1.4K 
CU6 03/05/24 0 275
03/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  275 

See All Discussions arrow Created with Sketch.

Timeline

Cleansing Notice
03 May 10:13
 
Application for quotation of securities - CU6
03 May 10:09
 
Clarity to Present at 3 World Leading Conferences
03 May 09:51
 
Change of Director's Interest Notice - Thomas
30 Apr 16:04
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 15:37
 
Complete response with Cu-67 SAR-bisPSMA
30 Apr 09:37
 
View More arrow Created with Sketch.
(20min delay)
Last
$3.90
Change
-0.060(1.52%)
Mkt cap ! $1.212B
Open High Low Value Volume
$3.97 $4.12 $3.81 $6.449M 1.625M

Buyers (Bids)

No. Vol. Price($)
1 3691 $3.90
 

Sellers (Offers)

Price($) Vol. No.
$3.95 4000 1
View Market Depth
Last trade - 16.10pm 10/05/2024 (20 minute delay) ?
Last
$3.90
  Change
-0.060 ( 0.92 %)
Open High Low Volume
$4.00 $4.13 $3.81 99015
Last updated 15.59pm 10/05/2024 ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.